FDANonrulemakingFDA-2017-N-6529

Who commented on this docket

FDA’s Approach to Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments

10 organizations filed 12 public comments on FDA’s Approach to Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments, at the Food and Drug Administration. The comment window closed 3085d ago.

Organizations
10
Comments
12
RIN
Comment window
closed 3085d ago

Commenters (10)

  • American Academy of Pediatrics (AAP)
    2 filings · confidence 97%
  • Foundation for a Smoke-Free Worldtrade assoc.
    2 filings · confidence 85%
  • American Association for Cancer Researchtrade assoc.
    1 filing · confidence 85%
  • American Cancer Society Cancer Action Networktrade assoc.
    1 filing · confidence 85%
  • American Lung Associationtrade assoc.
    1 filing · confidence 85%
  • American Thoracic Societytrade assoc.
    1 filing · confidence 85%
  • Association for the Treatment of Tobacco Use and Dependencetrade assoc.
    1 filing · confidence 85%
  • Harmless Product Companyunverified attribution
    1 filing · confidence 70%
  • Johnson & Johnson Consumer Services EAME Ltdunverified attribution
    1 filing · confidence 70%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.